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Introduction
There are a number of different conditions in
the important field of monogenic autoinflammatory
syndromes, including those provoked by mutations
of gene coding for proteins that play a pivotal role
in inflammatory response regulation(1).
Due to their genetic nature, most of these dis-
orders have an early onset, ranging from the first
hours to the second decade of life, and rarely occur
in adulthood. Autoinflammatory syndromes are
clinically characterized by recurrent flare of sys-
temic inflammation, in the majority of cases
appearing as sudden fever episodes associated with
elevation of acute-phase reactants, with a number
of clinical manifestations, such as rash, serositis
(peritonitis, pleurisy), arthritis, myositis, lym-
phadenopathy and hepatosplenomegaly. Symptom-
free intervals are characterized by complete wellbe-
ing, normal growth and complete normalization of
acute phase reactants(2).
In this report we describe the case of a twenty-
year-old woman with recurrent fever unresponsive
to antibiotic therapy. Subsequently to the exclusion
of infectious, autoimmune and neoplastic causes,
and because of clinical features and persistence of
fever cycles unresponsive to antibiotic therapy, an
autoinflammatory periodic fever was suspected. For
this reason, a treatment with nonsteroidal anti-
inflammatory drugs (NSAIDs) was started, with
fever and symptom disappearance, normalization of
inflammatory markers and cholesterol levels, and
regression of leucopenia and thrombocytopenia.
Case presentation
A twenty-year-old female with nothing rele-
vant in family and personal medical history until
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the age of 15 years old, when night fever appeared,
accompanied by shaking chills and followed by
profuse sweating (axillary T. max: 39°C), treated
with antibiotics (amoxicillin-clavulanic acid) with
little benefit. Thereafter, because of the persistence
of fever, she was admitted to the Division of
Infectious Diseases of a Sicilian hospital. During
hospitalization, pancytopenia, hyper-transami-
nasemia, increased alkaline fosfatasemia and γ-GT,
and hyper-γ-globulinaemia were found. After isola-
tion of Leishmania in marrow aspiration, she was
diagnosed with “visceral leishmaniasis” and treat-
ment started with N-methylglucamine antimoniate
cycles, with apparent benefit (disappearance of
fever). In July 2003, night fever (axillary T. max:
39°C) appeared again, not associated with other
symptoms, resistant to antibiotic therapy (amoxi-
cillin-clavulanic acid) and regressed spontaneously
after 10 days. In July 2004, a further febrile episode
(axillary T. max: 39°C), accompanied by asthenia,
treated by family members with nimesulide as
needed, with benefit (disappearance of fever in
about a week.). In October 2004, there was a new
onset of night fever (T. axillary max: 40°C), accom-
panied by chills and sweats, treated with antibiotics
(moxifloxacin for 4 days, and then cefpodoxime for
6 days) and steroids (methylprednisolone for 5
days), without benefit.
The patient was readmitted to the same
Division of Infectious Diseases, where the possibil-
ity of recurrence of visceral leishmaniasis was con-
sidered, and for this reason therapy was undertaken
with liposomal amphotericin B and subsequently
with N-methylglucamine antimoniate, but without
benefit. During this hospitalization, in addition to
fever, bilateral diffuse arthralgia appeared, with
weight loss of about 10 kg. Thus the patient came
to our Department for further investigation and
treatment. On admission patient was lucid, coopera-
tive, oriented in time and space, eupneic, pyretic.
There was nothing relevant on physical examina-
tion, except for pale and dehydrated skin and
mucous membranes, and mild hepatosplenomegaly.
There were no signs of local inflammation of
the joints. Blood tests showed: pancytopenia (sus-
pected iron deficiency anemia (hemoglobin, HGB,
6.9g/dl, ferritinemia 4ng/ml, serum iron 21mcg/ml),
leucopenia (white blood cells, WBC, 2280 x mmc),
with preservation of differential leukocyte count,
mild thrombocytopenia (120,000 x mmc), elevation
of inflammatory markers (erythrocyte sedimenta-
tion rate, ESR: 1st hour 91 mm, C-reactive protein,
CRP: 6.4mg/dl, increase of alpha-globulins) and
total hypocholesterolemia (99mg/dl). During hospi-
talization daily intermittent fever was observed, i.e.
night fever with max temperature of 40°C con-
firmed in double (axillary and rectal) measurement,
associated with diffuse bilateral arthralgia, without
signs of local inflammation of the joints. Aware of
the previous diagnosis of visceral leishmaniasis, the
characteristics of the fever, and assuming an infec-
tious etiology, we performed serology for
Salmonella, Brucella, Toxoplasma and Leishmania,
hepatitis serology markers (HBsAg, anti-HBs, anti-
HBc, anti-HCV), Leishmania in peripheral blood
and in the microscope slides supplied by the
Hospital where the patient was previously hospital-
ized (without evidence of Leishmania promastig-
otes), serial blood cultures and, moreover, a
Mantoux test, all proved negative. In addition we
treated the patient with a parenteral broad-spectrum
antibiotic therapy with vancomicin plus gentamicin,
without benefit. Once we excluded the infectious
nature of the disease, we then considered an
autoimmune genesis and subsequently a neoplastic
origin, leading to second and third level fever of
unknown origin (FUO) investigations (see Table 1).
The following tests were all negative: assays
of serum immunoglobulins (IgG, IgA and IgM),
complement components 3 and 4, circulating
immune complexes (CIC-IgG, IgA and IgM), eval-
uation of full autoreactive antibodies pattern (anti-
nuclear, ANA, double strand anti-DNA, anti-
dsDNA, anti-mitochondrial, AMA, anti-smooth
muscle, ASMA, extractable nuclear antigen, ENA,
anti-neutrophil cytoplasmic, ANCA antibodies) and
rheumatoid factor, as well as direct and indirect
Coombs test. Instrumental investigations: radiogra-
phy of paranasal sinuses, dental orthopantomogra-
phy, chest X-Ray, adbominal ultrasound, whole-
body Computerized Tomography (CT scan) exclud-
ed expansive processes, confirmed mild
hepatosplenomegaly and revealed a mild lateral
cervical lymphadenopathy subsequently subjected
to biopsy, with results of “reactive hyperplasia.”
We also performed a whole-body positron
emission tomography PET investigation, which
detected an area of increased uptake in the right
thigh (Figure 1), not confirmed by X-Ray examina-
tion and nuclear magnetic resonance NMR. After
administration of NSAIDs, fever and arthralgia pro-
gressively disappeared, with recovery of kinesthe-
sia and body weight, regression of leucopenia and
thrombocytopenia, improvement of anemia (HGB
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FIST LINE EXAMINATIONS
Erythrocyte sedimentation rate
C reactive protein
Hemoglobin and mean cellular volume 
Platelet count
Absolute and differential leukocyte count 
Lactate dehydrogenase
Blood urea nitrogen and serum creatinine
Serum sodium
Serum potassium
Serum protein fractions 
Serum alkaline phosphatase
Urine analysis
Fecal occult blood test (at least three times) 
Antistreptolysin O antibodies
Tuberculin skin testing
Blood cultures (at least three times) 
Urine cultures
Fecal cultures
Sputum cultures
Chest X-ray
Ultrasound of the abdomen
SECOND LINE EXAMINATIONS
Serology for Cytomegalovirus, Epstein-Barr virus, hepatitis viruses, Mycoplasma,
Chlamydia, Brucella, Salmonella, Toxoplasma and Leishmania
Sputum for acid fast bacilli
Polymerase chain reaction for tuberculosis
Urine cultures for tuberculosis
Rheumatoid factor
Antinuclear antibodies 
Serum levels of CH50, C3 and C4
TSH, fT4, fT3, thyroglobulin and thyroperoxidase antibodies 
Immunoelectrophoresis of serum
Radiography of paranasal sinuses
Dental orthopantomography
Echocardiography
Computed tomography of chest and abdomen
THIRD LINE EXAMINATONS
Esophagogastroduodenoscopy
Colonoscopy
Bone marrow aspiration or biopsy
Lymph node biopsy
Liver biopsy
Table 1: First, second and third-line examinations for patients with fever of unk-
nown origin.
9.6g/dl), and in serum markers of inflammation,
and normalization of serum cholesterol. Therefore,
it was assumed that the patient suffered from an
autoinflammatory periodic fever and, for this rea-
son, genetic testing was performed on the MEFV
gene, related to Familial Mediterranean Fever
(FMF), the well-known and most studied autoin-
flammatory disease(3). However, the test results
were negative. After 5 years of follow-up, the
patient is in good general clinical condition with
only periodic febrile episodes (2 times a year), with
the same clinical and blood chemistry characteris-
tics of the past, successfully treated with NSAIDs
within 1-2 weeks and without any appearance of
additional symptoms and/or signs of organ damage
and/or deterioration of general clinical condition.
Ultrasound examination of the right thigh, per-
formed one year later, showed no significant mor-
phological-structural alterations.
Discussion
The correct approach to investigate a FUO is
to examine the causes that may determine fever in
the context of infectious, autoimmune or neoplastic
diseases(4,5). In our case, all the investigations car-
ried out were negative, and led us to hypothesize
that our patient was suffering from an autoinflam-
matory disease(6).
The term “autoinflammatory” refers to a group
of diseases triggered by mutation of a single gene
encoding regulatory proteins of inflammatory
response(7). The onset is typically early, during the
first or second decade of life, rarely in adulthood.
The clinical spectrum is very variable, but for sim-
plicity they are divided into four groups: periodic
fevers, cryopyrin-associated periodic syndromes
(CAPS), granulomatous diseases, and pyogenic dis-
orders (Table 2)(8).
Periodic fevers (such as FMF) are character-
ized by periodic episodes of systemic inflammation,
with fever that may be associated with one or more
symptoms and/or signs, such as rash, arthralgia,
myalgia, pleurisy and pericarditis(9). CAPS (such as
Muckle-Wells syndrome) are characterized by fever
and cutaneous rash(10). Granulomatous diseases
(such as Blau’s syndrome) are characterized by the
presence of granulomatous inflammatory infiltrate,
with characteristic triad of dermatitis, arthritis and
uveitis(11). Pyogenic disorders (such as Pyogenic
sterile Arthritis, Pyoderma gangrenosum, Acne, or
PAPA syndrome), are characterized by sterile
abscesses of joints, bones and skin(12).
Considering the previous diagnosis of visceral
leishmaniasis based on marrow aspiration, we
examined the microscope slides in our laboratory,
and no Leishmania promastigotes were found,
hence the diagnosis of leishmaniasis was exclud-
ed(13). However, we considered a possible infectious
origin of the patient’s disease (mild
hepatosplenomegaly and lateral cervical lym-
phoadenopathy), and for this reason the patient
underwent serology for Salmonella, Brucella,
Toxoplasma, hepatitis serology markers, Mantoux
test and serial blood cultures (all were negative),
and ex-adiuvantibus antibiotic treatment was unsuc-
cessful. Because of fever pattern, elevation of
inflammatory markers and associated arthralgias,
we proceeded with immunological investigations,
in particular dosage of immunoglobulins, comple-
ment factors and full pattern of non-organ specific
autoantibodies. All results were normal.
Considering a potential neoplastic origin, the
patient underwent a total-body CT, which only con-
firmed mild hepatosplenomegaly. Even though the
CT did not detected any neoplasm, a whole-body
PET investigation was carried out and it revealed
the presence of increased uptake at the inner face of
the right thigh, of possible inflammatory nature.
Subsequently NMR investigation was performed
and did not confirm the finding mentioned above.
Due to the failure in determining fever origin and
unresponsiveness to antibiotic therapy, during hos-
pitalization the patient was treated with NSAID
therapy, with progressive disappearance of fever
and associated symptoms. Therefore, the patient
was discharged with NSAID therapy at home, and a
genetic test for MEFV gene mutations, responsible
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Figure 1: whole-body positron emission tomography
(PET) investigation of the patient, detecting an area of
increased uptake in the right thigh.
for FMF, was carried out(14) but it was negative.
Nevertheless, this fact does not exclude the possi-
bility that the patient suffers from another autoin-
flammatory disease, due to the clinical characteris-
tics of fever and associated symptoms; and because
the diagnosis of this kind of pathology remains
clinical(15,16), despite the availability of genetic test-
ing, there is a possibility of other autoinflammatory
disease genetic variants yet to be demonstrated.
Considering clinical and biochemical patient
features, it could be tumor necrosis factor receptor-
associated periodic syndrome (TRAPS), the second
most common inherited recurrent fever syndrome
after FMF, caused by mutations in the tumor necro-
sis factor receptor 1 (TNFR1) gene (TNFRSF1A),
with autosomal dominant pattern(17). The majority of
TRAPS-related mutations are missense mutations
resulting in single amino acid substitutions in cys-
teine-rich domains, resulting in a TNFR1 protein
folded into an improper 3-dimensional shape. These
misfolded proteins are trapped within the cell and
are not able to be exposed on the cell surface to
interact with TNF. Inside the cell, these proteins are
clustered and are thought to be able to initiate alter-
native pathways that trigger the inflammation, lead-
ing to an excessive activation of the latter in people
with TRAPS. Moreover, because only one copy of
TNFRSF1A gene is mutated, some normal TNFR1
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DENOMINATION GENE
PERIODIC FEVERS
Familial Mediterranean fever (FMF) MEFV
Hyperimmunoglobulinemia D with recurrent fever (HIDS).
Now defined (along with mevalonic aciduria) as mevalonate
kinase deficiency
MVK
Tumor Necrosis Factor (TNF) receptor associated periodic
syndrome (TRAPS) TNFRSF1A
NALP12-associated periodic fever NALP12
CRYOPYRIN-ASSOCIATED PERIODIC
SYNDROMES (CAPS) or CRYOPYRINOPATHIES 
Muckle-Wells syndrome (urticaria, sensorineural deafness and
amyloidosis) NLRP3
Familial cold autoinflammatory syndrome (FCAS, formerly
termed familial cold-induced urticaria) NLRP3
Neonatal-onset multisystem inflammatory disease (NOMID,
also called chronic infantile neurologic cutaneous and articular
syndrome or CINCA) 
NLRP3
GRANULOMATOUS DISEASES
Periodic fever, aphthous stomatitis, pharyngitis and adenitis
(PFAPA syndrome) ?
Blau’s syndrome NOD2
PYOGENIC DISORDERS
Pyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA
syndrome) PSTPIP1
Deficiency of the interleukin-1 receptor antagonist (DIRA) IL1RN
Majeed syndrome (chronic multifocal osteomyelitis, congeni-
tal dyserythropoietic anemia and neutrophilic dermatosis LPIN2
Table 2 Classification of autoinflammatory diseases.
From Federici S, Caorsi R, Gattorno M. The autoinflammatory diseases. Swiss Med Wkly 2012;
142:w13602. doi:10.4414/smw.2012.13602. (modified)
proteins are synthesized and then stimulated by
TNF, increasing inflammation. It is unclear if dis-
ruption of the apoptosis pathway plays an addition-
al role in provoking the signs and symptoms of
TRAPS. Fever episodes usually occur spontaneous-
ly, but sometimes they can be brought on by a vari-
ety of triggers, such as minor injury, infection,
stress, exercise or hormonal changes. During
episodes of fever, people with TRAPS can have fur-
ther signs and symptoms. These include a spreading
skin rash, typically found on the limbs, and abdom-
inal and muscle pain. Affected individuals may also
experience puffiness or swelling in the skin around
the eyes (periorbital edema), joint pain and inflam-
mation in various areas of the body including eyes,
certain joints, skeletal muscles (especially of
quadriceps), throat, or mucous membranes, such as
the moist lining of the mouth and digestive tract
(Table 3)(18).
Occasionally, people with TRAPS develop
amyloidosis, that can lead to kidney failure. It is
estimated that 15 to 20 percent of people with
TRAPS develop amyloidosis(19). In this context, our
patient showed, on whole-body PET, an area of
increased uptake in the right thigh, not confirmed
by X-Ray examination and NMR, suggesting
asymptomatic focal myositis, not confirmed in a
subsequent ultrasound exam(20).
After 5 years of follow-up, the patient is in
good general clinical condition and has only period-
ic febrile episodes (2 times a year), with the same
clinical characteristics and blood chemistry of the
past, successfully treated with NSAIDs within 1-2
weeks and without any appearance of additional
symptoms and/or signs of organ damage (i.e. renal
function), and/or deterioration of general clinical
condition(21).
In conclusion, we described the case of a
young woman, with recurrent fever, unresponsive
to antibiotic therapy, suspected of being autoinflam-
matory periodic fever (i.e. TRAPS), successfully
treated with NSAIDs. Diagnosis of autoinflamma-
tory disease, despite the availability of genetic test-
ing, remains clinical.
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